Werewolf Therapeutics Inc

NASDAQ:HOWL   1:20:55 PM EDT
17.50
+0.20 (+1.16%)
Earnings Announcements

Werewolf Therapeutics Reports Second Quarter 2021 Financial Results And Business Update

Published: 08/12/2021 11:14 GMT
Werewolf Therapeutics Inc (HOWL) - Werewolf Therapeutics Reports Second Quarter 2021 Financial Results and Business Update.
Werewolf Therapeutics - Expects Existing Cash Resources to Enable Funding Expenses and Capex Needs Through at Least Q2 of 2023.
Werewolf Therapeutics - Qtrly Loss per Share $3.82.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.